{"id":"lithium-or-lamotrigine","safety":{"commonSideEffects":[{"rate":"10-20%","effect":"Diarrhea"},{"rate":"10-20%","effect":"Nausea"},{"rate":"5-10%","effect":"Vomiting"},{"rate":"5-10%","effect":"Tremors"},{"rate":"5-10%","effect":"Weight gain"}]},"_chembl":null,"_dailymed":null,"mechanism":{"_ai_source":"groq-llama-8b","explanation":"Lithium is thought to increase the levels of these neurotransmitters, which helps to stabilize mood and reduce the risk of depression and mania. It also has anti-inflammatory properties and can affect the functioning of the brain's reward system.","oneSentence":"Lithium is a mood stabilizer that works by affecting the levels of certain neurotransmitters in the brain, such as serotonin and dopamine.","_ai_confidence":"high"},"_scrapedAt":"2026-03-28T01:19:10.140Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Bipolar disorder"},{"name":"Major depressive disorder"}]},"trialDetails":[{"nctId":"NCT06929273","phase":"PHASE3","title":"A Study to Assess the Long-term Safety of KarXT for the Treatment of Manic Episodes in Bipolar-I Disorder (BALSAM-3)","status":"RECRUITING","sponsor":"Bristol-Myers Squibb","startDate":"2025-07-18","conditions":"Bipolar Disorder Type I With Mania","enrollment":450},{"nctId":"NCT07140913","phase":"PHASE3","title":"A Study to Evaluate the Efficacy and Safety of Adjunctive KarXT for the Treatment of Mania, With or Without Mixed Features, in Participants With Bipolar-I Disorder Taking Lithium, Valproate, or Lamotrigine","status":"RECRUITING","sponsor":"Bristol-Myers Squibb","startDate":"2025-10-08","conditions":"Mania, Bipolar Disorder","enrollment":424},{"nctId":"NCT05603104","phase":"PHASE3","title":"Intensified Pharmacological Treatment for Schizophrenia, Major Depressive Disorder and Bipolar Depression After a First-time Treatment Failure","status":"RECRUITING","sponsor":"Dr. Inge Winter","startDate":"2025-04-27","conditions":"Schizophrenia and Related Disorders, Major Depressive Disorder, Bipolar Depression","enrollment":1254},{"nctId":"NCT01880957","phase":"NA","title":"PET and MRI Brain Imaging of Bipolar Disorder","status":"COMPLETED","sponsor":"Stony Brook University","startDate":"2011-11-08","conditions":"Bipolar Disorder, Bipolar Depression, Unipolar Depression","enrollment":76},{"nctId":"NCT00483548","phase":"PHASE3","title":"Adjunctive Ziprasidone in the Treatment of Bipolar I Depression","status":"COMPLETED","sponsor":"Pfizer's Upjohn has merged with Mylan to form Viatris Inc.","startDate":"2007-10","conditions":"Bipolar Disorder, Depression, Bipolar","enrollment":298},{"nctId":"NCT01588457","phase":"PHASE4","title":"Sequential Multiple Assignment Treatment for Bipolar Disorder","status":"COMPLETED","sponsor":"The University of Texas Health Science Center at San Antonio","startDate":"2011-06","conditions":"Bipolar I Disorder, Bipolar II Disorder","enrollment":112},{"nctId":"NCT02374567","phase":"PHASE3","title":"Pharmacovigilance in Gerontopsychiatric Patients","status":"TERMINATED","sponsor":"Hannover Medical School","startDate":"2015-01","conditions":"Dementia, Depression, Schizophrenia","enrollment":407},{"nctId":"NCT02413918","phase":"PHASE4","title":"Iloperidone in Mixed States of Bipolar Disorder","status":"COMPLETED","sponsor":"The University of Texas Health Science Center at San Antonio","startDate":"2012-04","conditions":"Bipolar Disorder","enrollment":41},{"nctId":"NCT00224510","phase":"PHASE3","title":"A Study To Investigate The Antidepressant Effect Of Lamotrigine In Patients With Bipolar Disorder Using Lithium","status":"COMPLETED","sponsor":"GlaxoSmithKline","startDate":"2002-08","conditions":"Bipolar Disorder, Bipolar Depression","enrollment":120},{"nctId":"NCT00562861","phase":"PHASE2, PHASE3","title":"Treatment for Bipolar Depression: Acute & Prophylactic Efficacy With Citalopram","status":"COMPLETED","sponsor":"Tufts Medical Center","startDate":"2007-11","conditions":"Bipolar Disorder, Bipolar Depression","enrollment":119},{"nctId":"NCT00063362","phase":"PHASE3","title":"Combination Therapy for the Treatment of Bipolar Disorders","status":"TERMINATED","sponsor":"University Hospitals Cleveland Medical Center","startDate":"2002-02","conditions":"Bipolar Disorder","enrollment":49},{"nctId":"NCT00272025","phase":"PHASE1","title":"Treatment Resistant Bipolar Depression","status":"TERMINATED","sponsor":"Queen's University","startDate":"2006-10","conditions":"Bipolar Depression","enrollment":1},{"nctId":"NCT01689389","phase":"","title":"Description of the Use of Quetiapine Extended Release (XR) in Real-life Practice in France. An Observational Study","status":"COMPLETED","sponsor":"AstraZeneca","startDate":"2012-12","conditions":"Schizophrenia, Bipolar Episodes","enrollment":2292},{"nctId":"NCT00221975","phase":"PHASE3","title":"Combination Therapy in Dual Diagnosis Bipolar Rapid Cycling","status":"COMPLETED","sponsor":"University Hospitals Cleveland Medical Center","startDate":"2002-07","conditions":"Bipolar Disorder","enrollment":98},{"nctId":"NCT00226135","phase":"PHASE3","title":"Prophylactic Effect of Lamotrigine Compared With Lithium in Bipolar Disorder","status":"COMPLETED","sponsor":"University of Aarhus","startDate":"2001-03","conditions":"Bipolar Disorder","enrollment":150}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":94283,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":[],"phase":"phase_3","status":"active","brandName":"lithium or lamotrigine","genericName":"lithium or lamotrigine","companyName":"University of Aarhus","companyId":"university-of-aarhus","modality":"Small molecule","firstApprovalDate":"","aiSummary":"Lamotrigine is a small molecule that blocks the sodium channel alpha subunit, classified as a blocker. It has been studied for various conditions, including bipolar disorders and schizophrenia, as part of clinical trials.","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":0,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}